Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

200.12B

Market cap200.12B

Price-Earnings ratio

11.04

Price-Earnings ratio11.04

Dividend yield

2.61%

Dividend yield2.61%

Average volume

14.90M

Average volume14.90M

High today

$45.72

High today$45.72

Low today

$44.15

Low today$44.15

Open price

$44.83

Open price$44.83

Volume

22.27M

Volume22.27M

52 Week high

$64.16

52 Week high$64.16

52 Week low

$35.12

52 Week low$35.12

NVO News

TipRanks 4h

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 0.6%

Cboe data shows mixed options sentiment in Novo Nordisk (NVO), with shares up 26c, or 0.6%, near $44.55. Options volume running well above average with 88k cont...

Simply Wall St 4h

Novo Nordisk Stock May Be Below Fair Value On ZEUS Trial Fallout

After a three year stretch where Novo Nordisk stock has declined 50.5%, the valuation picture now looks more supportive than the share price performance suggest...

CNBC 4h

We're increasing our Eli Lilly price target after another beat-and-raise quarter

Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company's portfolio of GLP-1 drugs continues to...

Analyst ratings

54%

of 37 ratings

Buy

37.8%

Hold

54.1%

Sell

8.1%

More NVO News

Reuters 7h

Novo Nordisk wins Dutch court injunction in semaglutide patent infringement case - Reuters

...

MarketWatch 7h

How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?

In August 2024, Novo Nordisk bused its employees to the sprawling Roskilde fairgrounds outside Copenhagen for its annual summer party. The Danish company had ho...

Nasdaq 7h

Novo Nordisk Wins Dutch Court Injunction Against Compounded Semaglutide Nasal Spray

(RTTNews) - Novo Nordisk A/S (NVO) said Wednesday it secured a preliminary injunction from the District Court of The Hague against Ceban Ziekenhuisfarmacie B.V....

Bloomberg 8h

European Stocks Subdued as HSBC and Novo Nordisk Lead Declines

Markets European Stocks Subdued as HSBC and Novo Nordisk Lead Declines Facebook X LinkedIn Email Link Gift Facebook X LinkedIn Email Link Gift Gift this article...

Simply Wall St 10h

Novo Nordisk Stock Shock Has Investors Rethinking Obesity Drug Exposure

The recent pullback in Novo Nordisk stock after its guidance update has put a harsh spotlight on obesity and metabolic disorder therapeutics. The market reactio...

The Wall Street Journal 10h

Novo Nordisk CEO Remains Open to Bolt-On Acquisitions, But Rules out Transformative Deals

Novo Nordisk’s Wegovy pill launched this year and has continued to show strong growth. Tom Little / Reuters Wegovy maker Novo Nordisk NOVO.B -5.79 %decrease; d...

The Wall Street Journal 16h

Temasek-Backed Manipal Health Shares Surge in Indian Trading Debut

Manipal is India’s largest private hospital group by bed capacity with nearly 50 hospitals and over 13,000 beds across the country. Priyanshu Singh / Reuters S...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.